{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:12:47Z","timestamp":1793729567741,"version":"4.6.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Update"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.tru.2021.100086","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T02:19:00Z","timestamp":1636510740000},"page":"100086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Vaccine-induced thrombosis and thrombocytopenia (VITT) in Ireland: A review of cases and current practices"],"prefix":"10.1016","volume":"5","author":[{"given":"D.","family":"Swan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Enright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Desmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"El Hassadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hennessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lynott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"O'Keeffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ni Ainle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"O'Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tru.2021.100086_bib2","article-title":"Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study","volume":"373","author":"Lopez Bernal","year":"2021","journal-title":"BMJ"},{"issue":"22","key":"10.1016\/j.tru.2021.100086_bib3","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.tru.2021.100086_bib4","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.tru.2021.100086_bib5","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.tru.2021.100086_bib6","first-page":"2448","article-title":"US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination","volume":"325","author":"See","year":"2021"},{"issue":"7","key":"10.1016\/j.tru.2021.100086_bib7","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/jth.15346","article-title":"Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)","volume":"19","author":"Thaler","year":"2021","journal-title":"J. Thromb. Haemostasis"},{"issue":"20","key":"10.1016\/j.tru.2021.100086_bib8","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tru.2021.100086_bib9","doi-asserted-by":"crossref","DOI":"10.7326\/L21-0244","article-title":"Thrombosis with thrombocytopenia after the messenger RNA\u20131273 vaccine","author":"Sangli","year":"2021","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.tru.2021.100086_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/ATVBAHA.120.315445","article-title":"Heparin-induced thrombocytopenia: a focus on thrombosis","volume":"41","author":"Arepally","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.tru.2021.100086_bib11","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J. Thromb. Haemostasis"},{"issue":"2","key":"10.1016\/j.tru.2021.100086_bib12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1358863X19898253","article-title":"Heparin-induced thrombocytopenia (HIT): review of incidence, diagnosis, and management","volume":"25","author":"Hogan","year":"2020","journal-title":"Vasc. Med."},{"issue":"7873","key":"10.1016\/j.tru.2021.100086_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tru.2021.100086_bib14","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2021013231","article-title":"Insights in ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia (VITT)","author":"Greinacher","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.tru.2021.100086_bib15","doi-asserted-by":"crossref","first-page":"L1218","DOI":"10.1152\/ajplung.2000.279.6.L1218","article-title":"Reversibility of increased microvessel permeability in response to VE-cadherin disassembly","volume":"279","author":"Gao","year":"2000","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"2","key":"10.1016\/j.tru.2021.100086_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.gene.2015.05.065","article-title":"HEK293 in cell biology and cancer research: phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution","volume":"569","author":"Stepanenko","year":"2015","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.tru.2021.100086_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-0037-1607202","article-title":"Two sides of the same coin?","volume":"44","author":"Lippi","year":"2018","journal-title":"Semin. Thromb. Hemost."},{"issue":"8","key":"10.1016\/j.tru.2021.100086_bib18","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3324\/haematol.2021.279075","article-title":"Post-mortem findings in vaccine-induced thrombotic thombocytopenia","volume":"106","author":"Pomara","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.tru.2021.100086_bib19","author":"Agency EM"},{"issue":"23","key":"10.1016\/j.tru.2021.100086_bib20","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine\u2013induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tru.2021.100086_bib21","author":"GotU"},{"key":"10.1016\/j.tru.2021.100086_bib22","author":"CfDCaPEPa"},{"key":"10.1016\/j.tru.2021.100086_bib23","series-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. New England journal of medicine","author":"Pavord","year":"2021"},{"key":"10.1016\/j.tru.2021.100086_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.17613","article-title":"Vaccine-induced immune thrombotic thrombocytopenia (VITT) \u2013 a novel clinico-pathological entity with heterogeneous clinical presentations","author":"Lavin","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.tru.2021.100086_bib25","article-title":"PF4-Dependent immunoassays in patients with vaccine-induced immune thrombotic thrombocytopenia: results of an interlaboratory comparison","author":"Sachs","year":"2021","journal-title":"Thromb. Haemostasis"},{"issue":"5","key":"10.1016\/j.tru.2021.100086_bib26","article-title":"Vaccine-induced immune thrombocytopenia and thrombosis (VITT)","volume":"5","author":"Makris","year":"2021","journal-title":"Res. Pract. Thrombosis Haemostasis"},{"key":"10.1016\/j.tru.2021.100086_bib27","series-title":"International society on thrombosis and haemostasis (ISTH). ISTH guidance on vaccine-induced immune thrombotic thrombocytopenia","author":"(ISTH) ISoTaH","year":"2021"},{"issue":"3","key":"10.1016\/j.tru.2021.100086_bib29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/a-1469-7481","article-title":"Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH","volume":"41","author":"Oldenburg","year":"2021","journal-title":"H\u00e4mostaseologie"},{"key":"10.1016\/j.tru.2021.100086_bib30","author":"Panel) EEH"},{"key":"10.1016\/j.tru.2021.100086_bib31","author":"Haematology ASo"},{"issue":"6","key":"10.1016\/j.tru.2021.100086_bib32","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/jth.15341","article-title":"Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: communication from the ISTH SSC subcommittee on platelet immunology","volume":"19","author":"Nazy","year":"2021","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.tru.2021.100086_bib33","author":"(NICE) NIoCE"},{"issue":"26","key":"10.1016\/j.tru.2021.100086_bib34","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1182\/blood.2021012064","article-title":"A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination","volume":"137","author":"Handtke","year":"2021","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.tru.2021.100086_bib35","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.3324\/haematol.2021.279000","article-title":"Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia","volume":"106","author":"Althaus","year":"2021","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.tru.2021.100086_bib36","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Bourguignon","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tru.2021.100086_bib37","series-title":"Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. Lancet","author":"Perry","year":"2021"},{"issue":"9","key":"10.1016\/j.tru.2021.100086_bib38","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood-2017-04-778993","article-title":"Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review","volume":"130","author":"Warkentin","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.tru.2021.100086_bib39","first-page":"171","article-title":"Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus","volume":"17","author":"Napolitano","year":"2019","journal-title":"Blood Transfus"},{"issue":"11","key":"10.1016\/j.tru.2021.100086_bib40","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/jth.14587","article-title":"The risk of major bleeding in patients with suspected heparin-induced thrombocytopenia","volume":"17","author":"Pishko","year":"2019","journal-title":"J. Thromb. Haemostasis"},{"issue":"9","key":"10.1016\/j.tru.2021.100086_bib41","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1182\/blood-2014-10-605493","article-title":"Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality","volume":"125","author":"Goel","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.tru.2021.100086_bib42","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1538-7836.2010.03861.x","article-title":"Outcomes after platelet transfusion in patients with heparin-induced thrombocytopenia","volume":"8","author":"Refaai","year":"2010","journal-title":"J. Thromb. Haemostasis"},{"issue":"1","key":"10.1016\/j.tru.2021.100086_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/rth2.12009","article-title":"Treatment of refractory delayed onset heparin-induced thrombocytopenia after thoracic endovascular aortic repair with intravenous immunoglobulin (IVIG)","volume":"1","author":"Doucette","year":"2017","journal-title":"Res. Pract. Thrombosis Haemostasis"},{"key":"10.1016\/j.tru.2021.100086_bib44","article-title":"Refractory heparin-induced thrombocytopenia with cerebral venous sinus thrombosis treated with IVIg, steroids, and a combination of anticoagulants: a case report","volume":"7","author":"Gonzales","year":"2019","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"7","key":"10.1016\/j.tru.2021.100086_bib45","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1182\/bloodadvances.2019001343","article-title":"IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP","volume":"4","author":"Carcao","year":"2020","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.tru.2021.100086_bib46","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJMc2109465","article-title":"Therapeutic plasma exchange in vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Patriquin","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.tru.2021.100086_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.transci.2013.01.007","article-title":"Refractory heparin induced thrombocytopenia with thrombosis (HITT) treated with therapeutic plasma exchange and rituximab as adjuvant therapy","volume":"49","author":"Schell","year":"2013","journal-title":"Transfus. Apher. Sci."},{"issue":"4","key":"10.1016\/j.tru.2021.100086_bib48","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood.2021011958","article-title":"Prothrombotic immune thrombocytopenia after COVID-19 vaccination","volume":"138","author":"Tiede","year":"2021","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.tru.2021.100086_bib49","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/jth.15352","article-title":"An observational study to identify the prevalence of thrombocytopenia and anti-PF4\/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination","volume":"19","author":"S\u00f8rvoll","year":"2021","journal-title":"J. Thromb. Haemostasis"},{"issue":"4","key":"10.1016\/j.tru.2021.100086_bib50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/blood.2021012524","article-title":"Understanding VITT(ual) reality","volume":"138","author":"Rauova","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.tru.2021.100086_bib51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.2021012217","article-title":"Frequency of positive anti-PF4\/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2","volume":"138","author":"Thiele","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.tru.2021.100086_bib52","first-page":"57","article-title":"The association of anti-platelet factor 4\/heparin antibodies with early and delayed thromboembolism after cardiac surgery. Journal of thrombosis and haemostasis :","volume":"15","author":"Welsby","year":"2017","journal-title":"JTH"},{"key":"10.1016\/j.tru.2021.100086_bib53","article-title":"Platelet activation by vaccine-induced immune thrombotic thrombocytopenia (VITT) patient serum is blocked by COX, P2Y12 and kinase inhibitors","volume":"2021","author":"Smith","year":"2021","journal-title":"medRxiv"},{"issue":"2","key":"10.1016\/j.tru.2021.100086_bib54","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2141.1986.tb04128.x","article-title":"Heparin-induced thrombocytopenia: further studies of the effects of heparin-dependent antibodies on platelets","volume":"64","author":"Chong","year":"1986","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.tru.2021.100086_bib55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bjh.12059","article-title":"Guidelines on the diagnosis and management of heparin-induced thrombocytopenia","volume":"159","author":"Watson","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.tru.2021.100086_bib56","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood-2012-09-457739","article-title":"Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network","volume":"121","author":"Stalker","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tru.2021.100086_bib57","article-title":"COVID-19 vaccine-induced immune thrombosis with thrombocytopenia (VITT) and the shades of grey in thrombus formation","author":"Thachil","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"issue":"22","key":"10.1016\/j.tru.2021.100086_bib58","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.tru.2021.100086_bib59","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2112760","article-title":"Decline in pathogenic antibodies over time in VITT","author":"Sch\u00f6nborn","year":"2021","journal-title":"N. Engl. J. Med."}],"container-title":["Thrombosis Update"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666572721000559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666572721000559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:18:52Z","timestamp":1763000332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666572721000559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":57,"alternative-id":["S2666572721000559"],"URL":"https:\/\/doi.org\/10.1016\/j.tru.2021.100086","relation":{},"ISSN":["2666-5727"],"issn-type":[{"value":"2666-5727","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine-induced thrombosis and thrombocytopenia (VITT) in Ireland: A review of cases and current practices","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Update","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tru.2021.100086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100086"}}